Publikation: Bio-orthogonal Immobilization of Fibroblast Growth Factor 2 for Spatial Controlled Cell Proliferation
Dateien
Datum
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
DOI (zitierfähiger Link)
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Publikationsstatus
Erschienen in
Zusammenfassung
Presentation of therapeutic proteins on material surfaces is challenged by random immobilization chemistries through lysine or cysteine residues, typically leading to heterogeneous product outcome. Pharmaceutical quality standards warrant a controlled process ideally through site specific conjugation. Therefore, we deployed genetic codon expansion to engineer a propargyl-l-lysine (Plk)-modified FGF-2 analogue, enabling site-specific copper(I)-catalyzed azide alkyne cycloaddition (CuAAC). Site-specific decoration of Plk-FGF-2 to particles sparked cell proliferation of human osteosarcoma cells in a spatially controlled manner around the decorated carrier, rendering this approach instrumental for the future design of quality-improved bioinstructive scaffold outcome.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
Schlagwörter
Konferenz
Rezension
Zitieren
ISO 690
LÜHMANN, Tessa, Gabriel JONES, Marcus GUTMANN, Jens-Christoph RYBAK, Joachim NICKEL, Marina RUBINI, Lorenz MEINEL, 2015. Bio-orthogonal Immobilization of Fibroblast Growth Factor 2 for Spatial Controlled Cell Proliferation. In: ACS Biomaterials Science & Engineering. 2015, 1(9), pp. 740-746. eISSN 2373-9878. Available under: doi: 10.1021/acsbiomaterials.5b00236BibTex
@article{Luhmann2015Bioor-32668, year={2015}, doi={10.1021/acsbiomaterials.5b00236}, title={Bio-orthogonal Immobilization of Fibroblast Growth Factor 2 for Spatial Controlled Cell Proliferation}, number={9}, volume={1}, journal={ACS Biomaterials Science & Engineering}, pages={740--746}, author={Lühmann, Tessa and Jones, Gabriel and Gutmann, Marcus and Rybak, Jens-Christoph and Nickel, Joachim and Rubini, Marina and Meinel, Lorenz} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/32668"> <dc:creator>Rubini, Marina</dc:creator> <dc:contributor>Meinel, Lorenz</dc:contributor> <dc:contributor>Gutmann, Marcus</dc:contributor> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-01-21T08:48:35Z</dc:date> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/> <dc:creator>Gutmann, Marcus</dc:creator> <dc:contributor>Rubini, Marina</dc:contributor> <dc:language>eng</dc:language> <dcterms:issued>2015</dcterms:issued> <dcterms:title>Bio-orthogonal Immobilization of Fibroblast Growth Factor 2 for Spatial Controlled Cell Proliferation</dcterms:title> <dc:creator>Lühmann, Tessa</dc:creator> <dc:contributor>Nickel, Joachim</dc:contributor> <dc:creator>Meinel, Lorenz</dc:creator> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/> <dc:contributor>Jones, Gabriel</dc:contributor> <dc:contributor>Lühmann, Tessa</dc:contributor> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:creator>Rybak, Jens-Christoph</dc:creator> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-01-21T08:48:35Z</dcterms:available> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dcterms:abstract xml:lang="eng">Presentation of therapeutic proteins on material surfaces is challenged by random immobilization chemistries through lysine or cysteine residues, typically leading to heterogeneous product outcome. Pharmaceutical quality standards warrant a controlled process ideally through site specific conjugation. Therefore, we deployed genetic codon expansion to engineer a propargyl-l-lysine (Plk)-modified FGF-2 analogue, enabling site-specific copper(I)-catalyzed azide alkyne cycloaddition (CuAAC). Site-specific decoration of Plk-FGF-2 to particles sparked cell proliferation of human osteosarcoma cells in a spatially controlled manner around the decorated carrier, rendering this approach instrumental for the future design of quality-improved bioinstructive scaffold outcome.</dcterms:abstract> <dc:contributor>Rybak, Jens-Christoph</dc:contributor> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/32668"/> <dc:creator>Nickel, Joachim</dc:creator> <dc:creator>Jones, Gabriel</dc:creator> </rdf:Description> </rdf:RDF>